223 filings
8-K
COLL
Collegium Pharmaceutical Inc
24 May 24
Departure of Directors or Certain Officers
4:05pm
8-K
COLL
Collegium Pharmaceutical Inc
20 May 24
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
COLL
Collegium Pharmaceutical Inc
13 May 24
Other Events
8:05am
DEFA14A
COLL
Collegium Pharmaceutical Inc
10 May 24
Additional proxy soliciting materials
8:03am
8-K
COLL
Collegium Pharmaceutical Inc
10 May 24
Departure of Directors or Certain Officers
8:02am
8-K
go23r9
9 May 24
Collegium Reports First Quarter 2024 Financial Results
4:04pm
8-K
2kpubc87gchabru 33z
29 Apr 24
Entry into a Material Definitive Agreement
8:05am
8-K
2oew tmosf0lbv
11 Apr 24
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
8:00am
ARS
mdu6e3x
5 Apr 24
Annual report to shareholders
4:03pm
DEFA14A
oyh77bvkds5af
5 Apr 24
Additional proxy soliciting materials
4:03pm
8-K
xare2 k88
22 Feb 24
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
4:01pm
8-K
td6ssrl5102z6 64
3 Jan 24
Regulation FD Disclosure
8:03am
8-K
w6k abcp3ch
9 Nov 23
Other Events
8:05am
8-K
8m0gmbg
7 Nov 23
Collegium Reports Third Quarter 2023 Financial Results
4:01pm
8-K
1g5ek9fzvgn
24 Aug 23
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
8:05am
S-8
wnaqnzze
10 Aug 23
Registration of securities for employees
4:06pm